Exodus Point Capital Management, LP Abbott Laboratories Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 91,439 shares of ABT stock, worth $10.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

91,439

Previous 82,412 10.95%

Holding current value

$10.5 Million

Previous $8.56 Million 21.74%

% of portfolio

0.06%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $903,331 - $1.07 Million	9,027 Added 10.95%	91,439 $10.4 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $4.11 Million - $4.59 Million	40,791 Added 98.01%	82,412 $8.56 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $1.93 Million - $2.13 Million	-17,587 Reduced 29.7%	41,621 $4.73 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $5.66 Million - $6.79 Million	59,208 New	59,208 $5.73 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $16.3 Million - $19.2 Million	168,553 Added 953.14%	186,237 $18.9 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $1.11 Million - $1.31 Million	-11,729 Reduced 39.88%	17,684 $1.94 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $19.7 Million - $22.9 Million	-204,051 Reduced 87.4%	29,413 $2.85 Million
Q2 2022 Aug 19, 2022	BUY	$102.07 - $123.37 $5.11 Million - $6.17 Million	50,043 Added 27.28%	233,464 $25.4 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $20.9 Million - $25.5 Million	183,421 New	183,421 $21.7 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $8.01 Million - $9.8 Million	-69,311 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $8.09 Million - $8.95 Million	69,311 New	69,311 $8.19 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $4.17 Million - $4.91 Million	-39,443 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $5.86 Million - $6.91 Million	-53,850 Reduced 57.72%	39,443 $4.73 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $4.62 Million - $5.04 Million	-44,030 Reduced 32.06%	93,293 $10.2 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $10.2 Million - $12.3 Million	110,939 Added 420.48%	137,323 $14.9 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $2.02 Million - $2.59 Million	26,384 New	26,384 $2.41 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $379,809 - $555,385	-6,046 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $41,924 - $46,671	-534 Reduced 8.12%	6,046 $525,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $538,507 - $583,909	6,580 New	6,580 $551,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Abbott Laboratories Transaction History